Ransys AM 5 mg+40 mg (Tablet)
Unit Price: ৳ 18.00 (5 x 6: ৳ 540.00)
Strip Price: ৳ 108.00
Medicine Details
Category | Details |
---|---|
Generic | Amlodipine besilate olmesartan medoxomil |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Treatment of hypertension alone or with other antihypertensive agents
- Lowering blood pressure
- Initial therapy for patients likely to need multiple antihypertensive agents
Pharmacology
- Amlodipine as a dihydropyridine calcium channel blocker
- Greater effect on vascular smooth muscle cells than on cardiac muscle cells
- Olmesartan Medoxomil as an Angiotensin II receptor antagonist that blocks vasoconstrictor effects
- Amlodipine as a peripheral arterial vasodilator
- Inhibition of ACE (kinase II) by Olmesartan Medoxomil
Dosage & Administration
- 5/20 mg once daily as initial therapy
- Titration up to a maximum of 10/40 mg once daily
- Dose adjustment for elderly patients
- Titration based on individual patient's response
Interaction
- Potential attenuation by NSAIDs including selective COX-2 inhibitors
- Monitoring of blood pressure, renal function, and electrolytes in combination therapy
Contraindications
- Cannot be co-administered with Aliskiren in patients with diabetes
Side Effects
- Peripheral edema
- Headache
- Flushing
- Dizziness
- Sprue-like enteropathy
- Intestinal problems
Pregnancy & Lactation
- Pregnancy Category D
- Avoid use in 2nd and 3rd trimester
- Discontinuation upon detection of pregnancy
- Unknown excretion in human milk
- Consideration of drug importance to the mother when deciding on nursing
Precautions & Warnings
- Risk of hypotension in volume- or salt-depleted patients
- Risk of vasodilation in patients with severe aortic stenosis
- Increased risk of angina or acute MI in patients with severe obstructive coronary artery disease
- Caution in patients with hepatic impairment
Use in Special Populations
- No established safety and effectiveness in pediatric patients
- No overall differences in safety or effectiveness in geriatric patients
- Unknown effects in patients with renal or hepatic impairment
Overdose Effects
- No information on overdose effects in humans
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Store below 30°C
- Keep away from light
- Keep out of the reach of children
Related Brands
- Ransys AM 5 mg+20 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Tenivasc 5 mg+20 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Olmezest AM 5 mg+20 mg (Tablet) - sun-pharmaceutical-bangladesh-ltd
- Olmedip 5 mg+40 mg (Tablet) - ibn-sina-pharmaceuticals-ltd
- Olmedip 5 mg+20 mg (Tablet) - ibn-sina-pharmaceuticals-ltd